Quest PharmaTech (TSXV: QPT) is buying five late-stage immunotherapy products that used to belong to another Edmonton company, ViRexx.
Quest PharmaTech (TSXV: QPT) is buying five late-stage immunotherapy products that used to belong to another Edmonton company, ViRexx.
Comments
Want to discuss? Please read our Commenting Policy first.